(PharmaNewsWire.Com, January 17, 2018 ) The Europe Bio Surgery Market was worth USD 4.37 billion in 2016 and estimated to be growing at a CAGR of 8.43%, to reach USD 6.55 billion by 2021. Bio Surgery is an area dedicated to providing aid in surgery by focusing on an array of technologies to minimize the intra- and post-operative complications. Solutions commonly used in bio surgery comprise innovative, biologically based products for surgical conditions that are often difficult or expensive to manage otherwise.
Bio surgery uses biomaterial, therapeutic, and sophisticated device technologies to improve the health of patients in the orthopaedic and post-surgery care departments. Most bio surgery products work by facilitating homeostasis and tissue healing in surgery. An example of this is fibrin sealant which consists of human fibrinogen and thrombin and helps replicate the tissue healing process by facilitating clotting of blood and thereby stopping the bleeding.
The major driver of the Europe Bio Surgery market is the strong focus on research development, which in turn leads to the launch of various new products and various other technological advancements in the field. This along with the increasing number of surgeries due to changing lifestyles and the increasing consumer awareness serve as boosters for the market growth. The major factor restraining the Bio Surgery market in Europe is the non-acceptance of certain products such as human tissue, which is essential for regenerative purposes, due to ethical concerns in certain parts of the region. This along with the high costs and the stringent government regulations act as restraints for the market. The Europe Bio Surgery market is broadly classified into Sealants, Haemostatic Agents, Adhesion Barriers, Soft Tissue Attachments, Bone Graft Substitutes and Staple Line Reinforcement Agents on the basis of type and based on application they are classified under Orthopaedic, General, Neurological, Cardiovascular, Reconstructive, Gynaecological, Urological and Thoracic surgeries. Based on geography, the Europe market is divided into Italy, France, UK, Germany and Spain. The European region has the second highest market share globally only behind the likes of North America, albeit with a low CAGR rate. The low growth rate of the region can be attributed to the fact that most countries in the region are in their pinnacle of development and the room to grow is fast decreasing.
The Bio Surgery market is highly competitive with a large number of players. Key market players Baxter International, C.R. Bard, Johnson & Johnson, Covidien plc., Getinge Group, B. Braun Melsungen AG, Cryolife Inc., Stryker Corporation, Hemostasis LLC., and Sanofi Group.
Market Segmentation 1) Type Introduction Sealants Natural Synthetic and Semi-Synthetic Haemostatic Agents Adhesion Barriers Synthetic Natural Soft Tissue Attachments Synthetic Meshes Biological Meshes Bone Graft Substitutes Bone Allografts Demineralized Bone Matrix Bone Morphogenetic Proteins Synthetic Bone Grafts Staple Line Reinforcement Agents Y-o-Y Growth Analysis, By Type Market Attractiveness Analysis, By Type Market Share Analysis, By Type 2) Application Introduction Orthopaedic General Neurological Cardiovascular Reconstructive Gynaecological Urological Thoracic Y-o-Y Growth Analysis, By Application Market Attractiveness Analysis, By Application Market Share Analysis, By Application
Reasons to buy Europe Bio Surgery Market Research Report: Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis Study the micro environment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analysing the level of competition and business strategy development A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialties with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
